• This topic is empty.
Viewing 1 post (of 1 total)
  • Author
  • #4085

    The company is working with Bio-Rad Laboratories to bring a COVID-19 Droplet Digital PCR (ddPCR) test to the FDA for an Emergency Use Authorization (EUA) approval to support the escalating need for testing in the U.S. Currently, Biodesix anticipates that they could manage 1,000 tests per day in their Colorado lab, and depending on regulatory approvals could be up and running by the end of April. They are working on getting EUA approval from the FDA. 

    More Information 

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.